The AMaRC 18-02 study (IRIL) is now available at Concord Hospital

COVID-19 (also known as the Coronavirus disease 2019) is a respiratory illness caused by a novel (or new) coronavirus that was first identified in an outbreak in Wuhan, China in December 2019.

The theme for this year's Myeloma Action Month by the International Myeloma Foundation (IMF) is resilience

Featuring Dr Michael Low, Dr George Grigoriadis, Mr John Doutch and Ms Cathy Rose

Why does Myeloma Awareness Matter?

The AMaRC 18-02 study (IRIL) is now available at Royal Hobart Hospital

The AMaRC 18-02 study (IRIL) is now available at Calvary Mater Newcastle

Multiple Myeloma epidemiology and survival, a unique malignancy

The AMaRC 18-02 study (IRIL) is now available with Border Medical Oncology